P
PACB
Pacific Biosc
1.440
+0.020+1.41%Pre Market: 1.530 +0.090 +6.25%08:13 04/08 EDT
OPEN/PREV CLOSE1.390/1.420
TODAY RANGE1.360-1.470
VOL41.47K
MARKET CAP434.88M
52 WEEK RANGE0.8511-2.730
AVG VOL (3M)6.95M
% TURNOVER1.42%
TURNOVER--
P/E (TTM)-0.7906
% RANGE7.75%
EPS(TTM)-1.8215
P/E(FORWARD)-2.7429
P/B81.36
BVPS0.0177
DIVIDEND--
P/S2.717
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP393.76M
SHARES OUTSTANDING302.00M
NEXT EARNINGS04/08-04/13
FREE FLOAT273.44M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
NASDAQ·03/26 13:05
PacBio Wins Basecamp Research Deal for Trillion Gene Atlas Initiative
TipRanks·03/18 13:10
PacBio HiFi selected by Basecamp Research AI lab
Reuters·03/09 10:23
PACBIO <PACB.O>: BARCLAYS CUTS TARGET PRICE TO $1.5 FROM $2
Reuters·03/09 07:34
U.S. RESEARCH ROUNDUP-Dow, Oracle, Shopify
TipRanks·03/06 21:34
Pacific Biosciences Secures Key Patent License, Ends Litigation
Reuters·03/06 21:07
Pacific Biosciences Settles PGI Patent Litigation in $23M Deal
Seeking Alpha·03/06 18:44
Medpace, IQVIA upgraded at Barclays; says AI concerns are overdone
NASDAQ·03/06 14:14
COO Declines Despite Q1 Earnings Beat and Raised FY26 Outlook
Dow Jones·03/06 14:13
Pacific Biosciences Price Target Cut to $1.50/Share From $2.00 by Barclays
Dow Jones·03/06 14:13
Pacific Biosciences Cut to Underweight From Equal-Weight by Barclays
Same Industry
Name/Symbol
Change%
Price